Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults

Autor: Katharina Wittfeld, Mekala R. Raman, Sarah C. Conner, Asra Aslam, Alexander Teumer, Matthias Nauck, Norbert Hosten, Mohamad Habes, Charles DeCarli, Ramachandran S. Vasan, Alexa S. Beiser, Jayandra J. Himali, Sudha Seshadri, Hans J. Grabe, Claudia L. Satizabal
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Adult
Male
Aging
hippocampus
Clinical Sciences
metabolism [C-Reactive Protein]
Neurodegenerative
Alzheimer's Disease
Article
C-reactive protein
insulin-like growth factor
Alzheimer’s disease endophenotype
Clinical Research
Alzheimer Disease
Acquired Cognitive Impairment
Alzheimer's disease endophenotype
cohort study
2.1 Biological and endogenous factors
Humans
ddc:610
Aetiology
Insulin-Like Growth Factor I
analysis [Insulin-Like Growth Factor I]
Inflammation
Neurology & Neurosurgery
neuroimaging
General Neuroscience
diagnostic imaging [Inflammation]
white matter hyperintensity
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
General Medicine
Middle Aged
Magnetic Resonance Imaging
Brain Disorders
Psychiatry and Mental health
Clinical Psychology
C-Reactive Protein
Insulin-Like Growth Factor Binding Protein 3
Neurological
Dementia
Cognitive Sciences
Female
epidemiology
Geriatrics and Gerontology
diagnostic imaging [Alzheimer Disease]
Biomarkers
Zdroj: Journal of Alzheimer's disease 88(1), 311-322 (2022). doi:10.3233/JAD-220356
J Alzheimers Dis
Journal of Alzheimer's disease : JAD, vol 88, iss 1
Popis: Background: Insulin-like growth factor 1 (IGF-1) signaling has been implicated in Alzheimer’s disease pathogenesis, and further evidence suggests inflammation can be a moderator of this association. However, most research to date has been conducted on older adults. Objective: To investigate the association of serum IGF-1 and IGF binding protein 3 (IGFBP-3) concentrations with MRI markers of Alzheimer’s disease in predominantly middle-aged adults, and further assess moderation by chronic inflammation. Methods: We included participants from the Framingham Heart Study (n = 1,852, mean age 46±8, 46% men) and the Study of Health in Pomerania (n = 674, mean age 50±13, 42% men) with available serum IGF-1, IFGBP-3, as well as brain MRI. IGF-1 and IFGBP-3 were related to MRI outcomes (i.e., total brain, cortical gray matter, white matter, white matter hyperintensities (WMH), and hippocampal volumes) using multivariable regression models adjusting for potential confounders. Subgroup analyses by C-reactive protein (CRP) concentrations were also performed. Cohort-specific summary statistics were meta-analyzed using random-effects models and corrected for multiple comparisons. Results: Meta-analysis results revealed that higher IGF-1 concentrations were associated with lower WMH (estimate [β] [95% CI], –0.05 [–0.09, –0.02], p = 0.006) and larger hippocampal volumes (0.07 [0.02, 0.12], p = 0.01), independent of vascular risk factors. These associations occurred predominantly in individuals with CRP concentrations
Databáze: OpenAIRE